JDI-4 and JDI-12 can inhibit the growth of mixed lineage leukemia rearranged acute leukemia and other malignant hematopoietic cells, but not leukemia cells resistant to KDM3C depletion or cord blood cells. This evidence concerns the gene JMJD1C and leukemia.